Additional Information

Description

Rocuronium Bromide Injection, USP at a concentration of 10 mg/mL in a 10 mL multidose vial, is a neuromuscular blocking agent used primarily in anesthesia to induce muscle relaxation during surgical procedures.

This medication acts by competitively binding to the nicotinic acetylcholine receptors at the neuromuscular junction, thereby preventing the transmission of nerve impulses and effectively paralyzing skeletal muscles.

The multidose vial format of Rocuronium Bromide allows for repeated administrations throughout procedures, ensuring continuous muscle relaxation as required by anesthesiologists and surgical teams. Each administration is tailored to achieve optimal muscle relaxation suitable for intubation, surgical exposure, and other medical interventions that necessitate muscle control.

As a key component of balanced anesthesia protocols, Rocuronium Bromide offers predictable onset and duration of action, aiding in the smooth progression of surgeries while allowing for controlled ventilation and patient safety. Its pharmacokinetic profile includes rapid onset within one to two minutes and duration of approximately 30 to 60 minutes, making it suitable for both short and prolonged procedures.